Literature DB >> 16213149

The role of constitutively active Stat6 in leukemia and lymphoma.

Heather A Bruns1, Mark H Kaplan.   

Abstract

Signal transducers and activators of transcription (STAT) are a family of transcription factors that regulate a broad range of cellular processes, such as proliferation, differentiation, and survival, in a large variety of cell types. Because of their regulation of diverse cellular functions, their aberrant activation is frequently associated with disease development, particularly oncogenic diseases. Much evidence exists to suggest that STAT proteins play a significant role in cellular transformation. However, which STAT proteins and to what extent they cause transformation and subsequent disease progression are topics currently being investigated. In this review, we will report on the findings concerning the involvement of Stat6 in the development of lymphoma and leukemia. Mounting evidence, in both patients and mouse models, supports a model where Stat6 is not a mere bystander, but rather, plays an active role in promoting a transformed phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213149     DOI: 10.1016/j.critrevonc.2005.08.005

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  28 in total

1.  Differential IL-4/Stat6 activities correlate with differential expression of regulatory genes SOCS-1, SHP-1, and PP2A in colon cancer cells.

Authors:  Qin Yuan; Pin Dong Li; Ben Hui Li; Xian Zi Yang; Shuang Bing Xu; Xiao Hong Liu; Fu Xiang Zhou; Wen Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-07       Impact factor: 4.553

2.  Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.

Authors:  Sarah C Roode; Daniel Rotroff; Anne C Avery; Steven E Suter; Dorothee Bienzle; Joshua D Schiffman; Alison Motsinger-Reif; Matthew Breen
Journal:  Chromosome Res       Date:  2015-06-03       Impact factor: 5.239

Review 3.  PI3K and STAT3: a new alliance.

Authors:  Peter K Vogt; Jonathan Ross Hart
Journal:  Cancer Discov       Date:  2011-11       Impact factor: 39.397

4.  Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family.

Authors:  Sung Hoon Cho; Annie K Ahn; Prerna Bhargava; Chih-Hao Lee; Christine M Eischen; Owen McGuinness; Mark Boothby
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

5.  Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.

Authors:  Alyxzandria M Gaydosik; Dawn S Queen; Megan H Trager; Oleg E Akilov; Larisa J Geskin; Patrizia Fuschiotti
Journal:  Blood       Date:  2020-10-08       Impact factor: 22.113

6.  Constitutively active STAT6 predisposes toward a lymphoproliferative disorder.

Authors:  Mark H Kaplan; Sarita Sehra; Hua-Chen Chang; John T O'Malley; Anubhav N Mathur; Heather A Bruns
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

7.  How to deal with weak interactions in noncovalent complexes analyzed by electrospray mass spectrometry: cyclopeptidic inhibitors of the nuclear receptor coactivator 1-STAT6.

Authors:  David Touboul; Ludovic Maillard; Anja Grässlin; Roba Moumne; Markus Seitz; John Robinson; Renato Zenobi
Journal:  J Am Soc Mass Spectrom       Date:  2008-10-15       Impact factor: 3.109

8.  IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma.

Authors:  Katherine R Calvo; Bhavana Dabir; Alexandra Kovach; Christopher Devor; Russell Bandle; Amelia Bond; Joanna H Shih; Elaine S Jaffe
Journal:  Blood       Date:  2008-08-05       Impact factor: 22.113

Review 9.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

10.  Long-term survival in primary CNS lymphoma treated by high-dose methotrexate monochemotherapy: role of STAT6 activation as prognostic determinant.

Authors:  Seung-Ho Yang; Kun Soo Lee; Il Sup Kim; Jae Taek Hong; Jae Hoon Sung; Byung Chul Son; Sang Won Lee; Yong-Kil Hong
Journal:  J Neurooncol       Date:  2008-11-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.